Showing results (421-430 of 605) with videos related to

Sort By:
Pageof 61
Environmental Science & Technology|November 21, 2009
Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone systemWen-Guang Yu, Wei Liu, Yi-He Jin, et al.
The Science of the Total Environment|August 6, 2025
Associations between antenatal organophosphate pesticide exposure and pregnancy outcomes: The Japan Environment and Children's Study (JECS)Sachiko Baba, Kanami Tanigawa, Shoji F Nakayama, et al.
International Journal of Environmental Research and Public Health|October 23, 2021
Association between Haematological Parameters and Exposure to a Mixture of Organophosphate and Neonicotinoid Insecticides among Male Farmworkers in Northern ThailandNeeranuch Suwannarin, Tippawan Prapamontol, Tomohiko Isobe, et al.
Cancer Chemotherapy and Pharmacology|October 29, 2000
Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancerN Takigawa, Y Segawa, H Ueoka, et al.
Journal of Cellular Physiology|February 13, 2001
Stimulation of GATA-2 as a mechanism of hydrogen peroxide suppression in hypoxia-induced erythropoietin gene expressionM Tabata, T Tarumoto, K Ohmine, et al.
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|January 1, 1984
[The age incidence of spontaneous abortion]Y Shiina, K Okuyama, W Takeda, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|March 1, 1993
[A case of small cell bronchogenic carcinoma accompanied by polyneuropathy and SIADH]N Takigawa, T Ohnoshi, H Ueoka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1993
[Cytotoxic effect of topoisomerase II inhibitors against adriamycin- and etoposide-resistant small cell lung cancer sublines]N Takigawa, T Ohnoshi, H Ueoka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1992
[A case of locally advanced esophageal cancer effectively treated with concurrent chemotherapy and radiotherapy]Y Segawa, T Ohnoshi, H Ueoka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2005
Continued gefitinib treatment after disease stabilisation prolongs survival of Japanese patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experienceK Hotta, K Matsuo, H Ueoka, et al.
Pageof 61